Dobmeier, M. and Franke, C. and Haen, Ekkehard and Wolfersdorf, M. (2000) Psychopharmacologic treatment of mania: Results from AMUP Bayern. PSYCHOPHARMAKOTHERAPIE, 7 (3). pp. 130-135. ISSN 0944-6877
Full text not available from this repository.Abstract
The first choice far the treatment of mania are lithium and anticonvulsants like carbamazepine and valproate. Neuroleptics and benzodiazepines ave second choice drugs.. However, when looking at choice therapy conditions as documented by the AMUP Bayern (a Bavarian drug surveillance program), the drugs most frequently used for the treatment of mania are neuroleptics. 88% oof the patients with mania got at least one neuroleptic drug. Most of then? were treated with a combination of two or. three psychoactive drugs. Each patient received an average of 2.82 drugs. Lithium or anticonvulsants are often not used at all. These results suggest that it is necessary to elaborate standardized therapy guidelines to improve the pharmacologic treatment of mania in Germany The severity! of the disease and the experience of the clinicians, should play an important role among these considerations.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | BIPOLAR AFFECTIVE-DISORDER; HALOPERIDOL; ANTICONVULSANTS; CLONAZEPAM; LORAZEPAM; LITHIUM; mania; pharmacotherapy; drug surveillance |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Psychiatrie und Psychotherapie |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 30 Mar 2022 12:09 |
| Last Modified: | 30 Mar 2022 12:09 |
| URI: | https://pred.uni-regensburg.de/id/eprint/42308 |
Actions (login required)
 |
View Item |
